富血小板血 (PRP) 在勃起功能障碍 (ED) 中的有效性和安全性:系统性审查和元分析
Haotian Huang1, Jiao Qin2, Zhi Wen1
1Department of Urology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Translational andrology and urology
|July 10, 2024
概括
富血小板血 (PRP) 在老年男性治疗勃起功能障碍 (ED) 中显示出显著的疗效和安全性. 需要进一步的高质量研究来验证这些对ED治疗的有希望的发现.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 再生医学是一种再生医学.
背景情况:
- 勃起功能障碍 (ED) 是一种常见的疾病,影响着老年男性.
- 富血小板血 (PRP) 是一种新兴的治疗方法,对ED有潜在的益处.
- 这项研究调查了PRP在ED治疗中的安全性和有效性.
研究的目的:
- 评估富血小板血 (PRP) 作为治疗勃起功能障碍 (ED) 的疗效和安全性.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 搜索了PubMed,科学网,Embase和Cochrane受控试验注册表.
- 通过修改的Jadad和MINORS等级来评估研究质量.
主要成果:
- 包括7项非随机研究和3项RCT.
- 在PRP治疗后的1,3个月和6个月,国际勃起功能指数-勃起功能 (IIEF-EF) 评分显著改善.
- PRP治疗对最小临床重要差异 (MCID) 和缩速度峰值 (PSV) 有积极影响,但没有勃起硬度评分 (EHS) 或视觉模拟尺度 (VAS) 疼痛.
结论:
- 在治疗ED方面,PRP显示出显著的疗效和安全性.
- 大多数被纳入的研究都是单臂研究,这凸显了需要更高质量的证据的需要.
- 未来的研究应该集中在可靠的试验上,以确认PRP在ED管理中的有效性.
相关概念视频
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
144
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
144
01:20Disorders of the Male Reproductive System
381
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
381
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
166
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
166
01:17Male Sexual Response: Erection & Ejaculation
2.0K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
2.0K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
514
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
514
01:22Formation of the Platelet Plug
5.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.7K